Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There
Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...
Jumping Into The FDA Gamble: Initiating Hims & Hers With A Buy
Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...
Hims & Hers Health (NYSE:HIMS) Trading 2.1% Higher After Analyst Upgrade
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares shot up 2.1% during trading on Wednesday after Bank of America raised their price target on the stock from $21.00 to $22.00. Bank of ...
Zacks Investment Research on MSN21h
New Product Launches to Support HOLX Stock Amid Macro Issues
Hologic HOLX has been gaining from new strategic product launches across Diagnostics and Breast Health. However, ...
Hims & Hers to keep offering compounded Ozempic, Wegovy, WSJ reports
The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...
3 Growth Companies With Insider Ownership Up To 15%
As the U.S. stock market experiences a slight downturn, with major indices like the S&P 500 and Nasdaq Composite closing lower amid concerns about economic policies and inflation, investors are ...
Eli Lilly launches weight-loss drug Mounjaro in India, Reuters says
Eli Lilly (LLY) launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk (NVO) for a ...
Atour Lifestyle Holdings And 2 Other Insider-Favored Growth Stocks
As the U.S. stock market navigates a mixed trading environment, with major indices struggling to extend their recent rebound rally, investors are closely watching for signs of economic stability amid ...